Candel Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.113; its P/E ratio is -0.82; Candel Therapeutics is scheduled to report earnings on November 10, 2023, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	$ 7.00K	$ 31.00K	$ 31.00K
Gross Profit	-	-	$ 7.00K	-	-
EBIT	$ -8.97M	$ -8.90M	$ -5.33M	$ -8.88M	$ -8.75M
EBITDA	-	$ -9.10M	$ -5.58M	$ -8.68M	$ -8.57M
Net Income Common Stockholders	$ -9.61M	$ -8.79M	$ -5.11M	$ -8.69M	$ -4.15M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 51.89M	$ 59.26M	$ 70.06M	$ 77.18M	$ 86.78M
Total Assets	$ 58.71M	$ 67.24M	$ 77.69M	$ 85.01M	$ 93.30M
Total Debt	$ 22.78M	$ 22.79M	$ 22.80M	$ 22.81M	$ 22.80M
Net Debt	$ -29.11M	$ -36.47M	$ -47.26M	$ -54.38M	$ -63.99M
Total Liabilities	$ 27.94M	$ 27.59M	$ 29.98M	$ 32.88M	$ 33.23M
Stockholders Equity	$ 30.77M	$ 39.65M	$ 47.71M	$ 52.13M	$ 60.07M
Cash Flow	-
Free Cash Flow	-	$ -10.80M	$ -7.16M	$ -9.60M	$ -7.73M
Operating Cash Flow	-	$ -10.82M	$ -6.88M	$ -9.38M	$ -7.10M
Investing Cash Flow	-	$ 19.00K	$ -276.00K	$ -215.00K	$ -635.00K
Financing Cash Flow	-	-	$ 36.00K	$ 0.00	$ 22.00K

Currency in USD

Candel Therapeutics Earnings and Revenue History

Income Statement >

Candel Therapeutics Debt to Assets

Balance Sheet >

Candel Therapeutics Cash Flow

Cash Flow >

Candel Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing